A buyer-underwriting-focused guide to supplement company valuation, including normalized EBITDA, SDE, revenue quality, channel mix, brand strength, manufacturing model, diligence risk, valuation methods, seller proceeds, and the steps founders can take to improve sale outcomes.
A buyer-underwriting-first guide to nutraceutical M&A, including why supplements, vitamins, and nutrition brands are attracting buyers, how acquirers frame valuation, where diligence risk changes deal terms, and what founders should fix before going to market.
A buyer-underwriting-focused guide to supplement company valuation multiples, including EBITDA and revenue multiple ranges, how buyers interpret benchmarks, why channel mix and compliance risk change pricing, and how the same revenue or EBITDA can produce very different seller outcomes.